Oxidative stress and hypertension

International Journal of Clinical Practice

Volumn 60, Issue 12, 2006, Pages 1525-1527

  Karthikeyan, V J ^a   Lip, G Y H ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTIOXIDANT; LOSARTAN; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; SIMVASTATIN; SUPEROXIDE; VITAMIN;

ATHEROGENESIS; CARDIOVASCULAR DISEASE; EDITORIAL; ENDOTHELIAL DYSFUNCTION; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; ESSENTIAL HYPERTENSION; HEREDITY; HUMAN; HYPERTENSION; KIDNEY DISEASE; MONONUCLEAR CELL; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; SOCIAL ASPECT; STROKE; TREATMENT RESPONSE; WHITE COAT HYPERTENSION;

HUMANS; HYPERTENSION; OXIDATIVE STRESS;

EID: 33751014309     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2006.00963.x     Document Type: Editorial

References (15)

1. Tomson J, Lip GY. Blood pressure demographics: Nature or nurture... genes or environment? BMC Med 2005; 3: 3.
2. Stergiou GS, Efstathiou SP, Inglis GC, Connell JM, McInnes GT, Mountokalakis TD. Association of renin-angiotensin system gene polymorphisms with antihypertensive responses to angiotensin-converting enzyme inhibition or angiotensin receptor blockade. J Hum Hypertens 2005; 19: 971-4.
3. Boos CJ, Lip GY. Elevated high-sensitive C-reactive protein, large arterial stiffness and atherosclerosis. a relationship between inflammation and hypertension? J Hum Hypertens 2005; 19: 511-3.
4. Uzun H, Karter Y, Aydin S et al. Oxidative stress in white coat hypertension; role of paraoxonase. J Hum Hypertens 2004; 18: 523-8.
5. Pedro-Botet J, Covas MI, Martin S, Rubies-Prat J. Decreased endogenous antioxidant enzymatic status in essential hypertension. J Hum Hypertens 2000; 14: 343-5.
6. Curgunlu A, Uzun H, Bavunoglu I, Karter Y, Genc H, Vehid S. Increased circulating concentrations of asymmetric dimethylarginine (ADMA) in white coat hypertension. J Hum Hypertens 2005; 19: 629-33.
7. Jun T, Ke-yan F, Catalano M. Increased superoxide anion production in humans. a possible mechanism for the pathogenesis of hypertension. J Hum Hypertens 1996; 10: 305-9.
8. Russo C, Olivieri O, Girelli D et al. Anti-oxidant status and lipid peroxidation in patients with essential hypertension. J Hypertens 1998; 16: 1267-71.
9. Tandon R, Sinha MK, Garg H, Khanna R, Khanna HD. Oxidative stress in patients with essential hypertension. Natl Med J India 2005; 18: 297-9.
10. Caner M, Karter Y, Uzun H et al. Oxidative stress in human sustained and white coat hypertension. association with protein oxidation and antioxidants. Int J Clin Pract 2006; 60: 1565-71.
11. Celermajer DS. Endothelial dysfunction: Does it matter? Is it reversible? J Am Coll Cardiol 1997; 30: 801-9.
12. Maeda K, Yasunari K, Watanabe T, Nakamura M. Oxidative stress by peripheral blood mononuclear cells is increased in hypertensives with an extreme-dipper pattern and/or morning surge in blood pressure. Hypertens Res 2005; 28: 755-61.
13. Bayorh MA, Ganafa AA, Eatman D, Walton M, Feuerstein GZ. Simvastatin and losartan enhance nitric oxide and reduce oxidative stress in salt-induced hypertension. Am J Hypertens 2005; 18: 1496-502.
14. Garcia-Estan J, Ortiz MC, O'valle F et al. Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitricoxide-deficiency-induced hypertension in rats. Clin Sci (Lond) 2006; 110: 227-33.
15. Williams B, Poulter NR, Brown MJ et al. British Hypertension Society. Guidelines for management of hypertension: Report of the fourth Working Party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens 2004; 18: 139-85.